Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA(2)), UCM-14216, Ameliorates Spinal Cord Injury in Mice

[Image: see text] Spinal cord injuries (SCIs) irreversibly disrupt spinal connectivity, leading to permanent neurological disabilities. Current medical treatments for reducing the secondary damage that follows the initial injury are limited to surgical decompression and anti-inflammatory drugs, so t...

Descripción completa

Detalles Bibliográficos
Autores principales: Khiar-Fernández, Nora, Zian, Debora, Vázquez-Villa, Henar, Martínez, R. Fernando, Escobar-Peña, Andrea, Foronda-Sainz, Román, Ray, Manisha, Puigdomenech-Poch, Maria, Cincilla, Giovanni, Sánchez-Martínez, Melchor, Kihara, Yasuyuki, Chun, Jerold, López-Vales, Rubèn, López-Rodríguez, María L., Ortega-Gutiérrez, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421655/
https://www.ncbi.nlm.nih.gov/pubmed/35948083
http://dx.doi.org/10.1021/acs.jmedchem.2c00046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421655/
https://www.ncbi.nlm.nih.gov/pubmed/35948083
http://dx.doi.org/10.1021/acs.jmedchem.2c00046

Ejemplares similares